演讲题目
现代制药的第三次浪潮 – 小核酸制药进入黄金发展阶段

梁子才

苏州瑞博生物技术股份有限公司董事长&CEO

Zicai Liang, PhD, is the chairman and CEO of Suzhou Ribo Life Science Co., Ltd. He was trained as a biologist at Nankai University where he received his B.Sc. and M.Sc.degree and then as a molecular Biologist at Uppsala University where he obtained his Ph.D.degree in 1995. He is an expert of the National Thousand Talents Program and a tenure-track professor of Peking University. He has been deeply engaged in the research field of small nucleic acid for more than 20 years, published more than 120 academic articles, and presided over the first 863 key projects in the field of small nucleic acid in China. He is one of the main pioneers in the pharmaceutical industry of small nucleic acid in China. He once served as director of genomic and bioinformatics technology center for genome research in Karolinska institute, director of Nucleic Acid Technology Department, Institute of Molecular Medicine, Peking University and vice chairman of RNA Committee of China Society of Biochemistry and Molecular Biology.